Bristol Will Buy Diabetes Drug Maker

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

BING NEWS:
  • 4 Top Pharmaceutical Stocks to Buy for Market Safety
    The four top pharmaceutical stocks to buy now are Bristol-Myers Squibb Co. (NYSE ... In late December, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable (cannot ...
    03/10/2015 - 10:40 pm | View Link
  • AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion
    LONDON (Reuters) - AstraZeneca has agreed to buy Bristol-Myers Squibb’s stake in the ... received a boost when an advisory panel to the U.S. Food and Drug Administration endorsed its new diabetes pill dapagliflozin.
    12/18/2013 - 6:52 pm | View Link
  • Bristol-Myers Squibb to Buy Amylin for $7B
    What’s the Real Impact of Generic Drugs? Under the terms of the announced deal, Bristol-Myers Squibb will pay $31 a share for the diabetes drug developer, the Associated Press noted. The deal features a $5.3 billion cash payment, with the remaining $1.7 ...
    07/1/2012 - 10:24 pm | View Link
  • Bristol-Myers to acquire diabetes drug maker Amylin
    Amylin Pharmaceuticals Inc., the San Diego drug maker whose treatments include the diabetes therapies Bydureon and Byetta, will be acquired by Bristol-Myers Squibb Co. for $5.3 billion in cash. Bristol-Myers agreed to pay $31 a share for Amylin ...
    06/29/2012 - 1:00 pm | View Link
  • Bristol-Myers in Deal for Amylin Valued at $7 Billion
    Bristol-Myers Squibb agreed late on Friday to buy Amylin Pharmaceuticals, the maker of a promising new diabetes drug, in a complicated deal that is valued at about $7 billion. To help finance the transaction, Bristol-Myers is teaming up with AstraZeneca ...
    06/29/2012 - 11:29 am | View Link
  • More
BING SEARCH:
  • Bristol-Myers Squibb: Media
    Visit the Bristol-Myers Squibb newsroom & stay up to date with our most current news as we continue to make a difference in the lives of our patients.
    01/15/2018 - 4:51 pm | View Website
  • U.S. Food and Drug Administration (FDA) Accepts Bristol ...
    Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration has accepted its supplemental Biologics License Application for priority ...
    01/14/2018 - 10:07 pm | View Website
  • Bristol-Myers Squibb Co.
    View detailed financial information, real-time news, videos, quotes and analysis on Bristol-Myers Squibb Co. (NYSE:BMY). Explore commentary on Bristol-Myers Squibb Co ...
    01/14/2018 - 5:42 pm | View Website
  • News Tribune | Central MO Breaking News
    Daily paper. Local, state, and wire news and commentary. Photo galleries, business and obituaries.
    01/14/2018 - 3:48 pm | View Website
  • MRK Stock Price
    Merck and Pfizer diabetes drug approved by the FDA. Merck & Co. Inc. and Pfizer Inc. said Friday that the Food and Drug Administration has approved diabetes drug ...
    01/14/2018 - 10:11 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News